Spezial 1/ AT0000961032 /
| NAV26/07/2024 | Chg.+0.1100 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 63.5100EUR | +0.17% | paying dividend | Bonds Europe | Raiffeisen KAG ▶ |
GlobeNewswire
11/01
Pre-War Greats from Gregorie Neck Collection Join Growing Roster of Highlights for Broad Arrow Ameli...
GlobeNewswire
04/12/2023
China Medical System: NDA for Additional RA Indication of Methotrexate Injection Accepted in China
Newsfile Corp
29/06/2023
Indigo beginnt mit der Entnahme von Soleproben und beauftragt unabhängiges Labor mit der Analyse
GlobeNewswire
30/11/2021
It's About Time the BMX Got an Upgrade - turbospezial Creates the Fastest Acceleration Cruiser Bike
GlobeNewswire
23/07/2021
Biofrontera enters into license and supply agreement with Medac for the marketing of Ameluz® in Pola...
GlobeNewswire
13/03/2020
Biofrontera AG signs non-binding term sheet for licensing agreement for Ameluz® in Poland with medac...
GlobeNewswire
13/08/2019
Commercial & Military Parachute Market Set to Record a CAGR of Approx 5% Over 2019-2023
GlobeNewswire
26/02/2018
Enstar gibt Rückversicherung für Zurich Australias Versicherungsgeschäft in Bezug auf New South Wale...
GlobeNewswire
09/02/2017
Enstar Group Limited kündigt die Rückversicherung der Altbestände von RSA aus der Sparte der Arbeitg...
